Institutional Ownership
Apogee Therapeutics Inc
CUSIP 03770N101COMAPGEQ1 2026
13D / 13G Filings
31
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
16.7%
Max % of class reported
Institutional Holders
218
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
31 filings · latest Mar 6, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 6, 2026 | T. Rowe Price Investment Management, Inc. | 13G | 11.3% | 6.21M | SEC |
| 2 | Feb 17, 2026 | Rtw Investments, LP | 13G/A | 4.9% | 2.71M | SEC |
| 3 | Feb 10, 2026 | Wellington Management Group LLP | 13G/A | 8.7% | 4.75M | SEC |
| 4 | Jan 30, 2026 | The Vanguard Group | 13G | 5.2% | 2.86M | SEC |
| 5 | Jan 22, 2026 | Fairmount Funds Management LLC | 13D/A | 10.0% | — | SEC |
| 6 | Nov 14, 2025 | Driehaus Capital Management LLC | 13G/A | 4.7% | 2.16M | SEC |
| 7 | Oct 14, 2025 | Fairmount Funds Management LLC | 13D/A | 10.0% | — | SEC |
| 8 | Aug 6, 2025 | Fmr LLC | 13G/A | 15.0% | 6.91M | SEC |
| 9 | Aug 5, 2025 | Wellington Management Group LLP | 13G/A | 10.6% | 4.89M | SEC |
| 10 | Aug 5, 2025 | Wellington Management Group LLP | 13G/A | 8.3% | 3.81M | SEC |
21 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Apogee Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 9.26M | $779.61M |
| 2 | Venrock Adviser, LLC | 8.49M | $714.88M |
| 3 | Wellington Management Group LLP | 4.38M | $368.30M |
| 4 | Blackrock, Inc. | 4.09M | $343.89M |
| 5 | Rtw Investments, LP | 2.78M | $234.17M |
| 6 | Janus Henderson Group PLC | 2.36M | $198.81M |
| 7 | State Street Corp | 2.16M | $182.06M |
| 8 | Driehaus Capital Management LLC | 1.92M | $161.67M |
| 9 | Perceptive Advisors LLC | 1.54M | $129.65M |
| 10 | Paradigm Biocapital Advisors LP | 1.35M | $113.48M |